InsiderClue
Insiders · Profile

Regnante Keith

CHIEF FINANCIAL OFFICER at Keros Therapeutics · Chief Financial Officer at Wave Life Sciences. Filing since 16 Feb 2018. CIK 0001682068

KROS Keros Therapeutics, Inc. CHIEF FINANCIAL OFFICER · 4 trades WVE Wave Life Sciences, Inc. Chief Financial Officer · 3 trades
Company
Date
Role
Action
Shares
Amount
Of holding
KROS Keros Therapeutics, Inc.
18 Feb 2026
CHIEF FINANCIAL OFFICER
Sold at will
4,739
$77.48K
10.8%
KROS Keros Therapeutics, Inc.
4 Nov 2023
Chief Financial Officer
Sold at will
40,000
$1.81M
100%
KROS Keros Therapeutics, Inc.
9 Jun 2023
Chief Financial Officer
Sold on a plan
20,000
$908.37K
100%
KROS Keros Therapeutics, Inc.
8 Jun 2023
Chief Financial Officer
Sold on a plan
20,000
$955.87K
100%
WVE Wave Life Sciences, Inc.
19 Feb 2019
Chief Financial Officer
Sold, plan not stated
1,298
$47.82K
7.6%
WVE Wave Life Sciences, Inc.
24 Sep 2018
Chief Financial Officer
Sold, plan not stated
29,500
$1.62M
63.5%
WVE Wave Life Sciences, Inc.
16 Feb 2018
Chief Financial Officer
Sold, plan not stated
316
$16.38K
1.8%
7 decisions on file.